China Prescription Drug 2006 Issue 1 yao yuan xing yi xian yan : bu xing zhi shi

yao yuan xing yi xian yan : bu xing zhi shi

..............page:65

jing ti lai fu mi te yin qi de hu xi xi tong zheng zhuang

..............page:65

yao pin fen lei guan li jin ru xin jie duan

..............page:66

huang yu xi cheng ren pei tai gan xi bao zao jia / zhong guo di yi ge zhi liao xing zhi fang ru ji ji jiang shang shi / kong zhi xue tang jian shao tang niao bing shi wang mo bing bian

..............page:67

2006 nian , hui you na xie xin yao shang shi ?
heidi belden; shi cheng jun

..............page:68-69

ji xing guan mai zong he zheng gao wei ren qun xuan ze bu tong de gan su wu ming xian cha yi

..............page:70

pen qiang fang liao yu lao nian nv xing zuo guan jie gu zhe de fa sheng xiang guan

..............page:70

li lun shang bei te lei yao wu dui tang niao bing huan zhe you yi , shi ji shang bing bu jin ran

..............page:71

chuan tong kang jing shen bing yao wu yu xin xing kang jing shen bing yao wu si wang wei xian xiang si

..............page:71

hao wen zhang tui jian

..............page:72-73

qiu shui xian jian : di ji liang geng an quan

..............page:64

tong xi tong ju bu feng bi zhi liao yao zhui jian pan tu chu 758 li bao gao
zeng qing wen ; yuan yong xian

..............page:63

han jian de gao dian fen mei xue zheng bing li
rajeev srivastava;callum fraser;douglas gentleman; yang neng

..............page:61-62

yi li chi fa xing chan hou zi zuo de zhen zhi
nalini munjuluri;marc lipman;alan valentine; liang li

..............page:60-61

xin xue guan ji bing wei xian yin su de gan yu zhi liao
zheng bai qin

..............page:58-59

fa zhan zhong guo jia jie he bing kong zhi ce lue de cheng ben xiao yi fen xi
rob baltussen;katherine floyd;christopher dye; yin hui juan

..............page:54-57

fda zui xin yao wu
zhang jie ; yang chang shan

..............page:52-53

Cooperative cell-growth inhibition by combination treatment with ZD1839 (Iressa) and trastuzumab(Herceptin) in non-small-cell lung cancer

..............page:51

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials

..............page:50-51

A phase Ⅱ study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer

..............page:50

nan zhi xing zhong liu zhi liao de xin tu po -- duo ba dian kang ye suan zhi ji
yi zhou

..............page:49

xue guan sheng cheng yi zhi yin zi kang zhong liu zuo yong de yan jiu jin zhan
wu guo ming ; li kun lin

..............page:46-48

fei ai fen zi ba xiang zhi liao : ge ti hua zhi liao de xuan ze
han bao hui

..............page:42-45

vshi ye lun tan

..............page:74-75

vti yan diao cha

..............page:76

you fa fei shui zhong de yao wu
lu yue ming

..............page:39-41

The Management of Chronic Obstructive Pulmonary Disease
CHEN Sheng-wen

..............page:36-38

Advance in Drug Therapy for Airway Hypersecretion
BAI Chun-xue

..............page:33-35

The Progression of Management in Chronic Obstructive Pulmonary Disease
ZHOU Yu-qi;XIE Can-mao

..............page:29-32

qing mi " bi yan ai "-- ji zhong guo ke xue yuan yuan shi yao kai tai
wang xiao yan

..............page:26-28

Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis

..............page:25

zhi yi shi wo men zou xiang wan shan de fu shou
zhong guo chu fang yao bian ji bu

..............page:1

shou ti zu zhi ji , huan shi gao xue ya de yi xian yong yao ma ?

..............page:4-5

How to Evaluate the Role of Beta Receptor Blockers in Hypertension
SUN Ning-ling

..............page:6-7

Is It the End of Beta Receptor Blockers as First-line Drugs for Hypertension?
MA Hong

..............page:8-9

" shou ti zu zhi ji bu ying zuo wei yuan fa xing gao xue ya huan zhe de shou xuan yao wu " ma ?
chen lu yuan

..............page:10-11

shou ti zu zhi ji cong gao xue ya yi xian yong yao yin tui ? huan wei shi shang zao !-- fang bei jing da xue ren min yi yuan xin nei ke xu cheng bin jiao shou
gu miao

..............page:12-13

shou ti zu zhi ji zai zhi liao gao xue ya zhong de di wei
yu zhen qiu ; kong yu

..............page:14-17

jiang ya zhi liao , shou ti zu zhi ji huan xing me ?
xu jun tang

..............page:18-21

The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension

..............page:22

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study

..............page:22-23

Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy

..............page:23

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) Ⅲ

..............page:24